Corresponding symptoms

Retinitis pigmentosa is a chronic blinding disease in humans, with a clinical incidence of 1/4000. The treatment effect and prognosis are both very poor, and it can ultimately lead to blindness in patients. The pathological characteristics of retinitis pigmentosa (RP) mainly lie in the progressive degeneration of photoreceptor cells. Pipeline 3: iPSC-RPC transplantation for the treatment of retinitis pigmentosa

Retinal histological appearance: The retinas of a healthy person (left) and an RP patient in the middle stage of the disease

Therapeutic principle

Transplanting RPCs derived from pluripotent stem cells to protect the structure and function of the retina in RP patients.  Pipeline 3: iPSC-RPC transplantation for the treatment of retinitis pigmentosa

Experimental effect in the RP rat model

Pipeline progress

相关新闻

联系我们

联系我们

18058583267

邮件:jstg@tongeye.com

工作时间:周一至周五,9:00-18:00,节假日休息

关注微信
关注微信
SHARE
TOP